Industry News
Pharmaceutical Industry News
Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens.
Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall this week
Novartis' Sandoz, following Pfizer's lead, launches 2nd carcinogen-related drug recall this week fkansteiner Wed, 03/23/2022 - 14:55
Aurobindo to turn out lights at troubled New Jersey plant, putting 99 jobs on the chopping block
Aurobindo to turn out lights at troubled New Jersey plant, putting 99 jobs on the chopping block fkansteiner Wed, 03/23/2022 - 12:59
Komodo and cancer charity map out dealing with the colorectal cancer
Komodo and cancer charity map out dealing with the colorectal cancer sharon.coey Wed, 03/23/2022 - 12:08
Komodo and cancer charity map out dealing with colorectal cancer
Komodo and cancer charity map out dealing with colorectal cancer sharon.coey Wed, 03/23/2022 - 12:08
Epinephrine recall: Adamis pulls Symjepi injections for needle clogging risks
Epinephrine recall: Adamis pulls Symjepi injections for needle clogging risks aliu Wed, 03/23/2022 - 11:18
As Russian invasion persists, Roche, Teva, Novartis, Merck and more make renewed push to support besieged Ukraine
As Russian invasion persists, Roche, Teva, Novartis, Merck and more make renewed push to support besieged Ukraine fkansteiner Wed, 03/23/2022 - 10:55
UPDATED: AstraZeneca and Sanofi tweak stances on Russian operations as pharma contends with war in Ukraine
UPDATED: AstraZeneca and Sanofi tweak stances on Russian operations as pharma contends with war in Ukraine fkansteiner Wed, 03/23/2022 - 10:55
Moderna seeks FDA nod for COVID vaccine in children under 6, starts delayed filing for older kids
Moderna seeks FDA nod for COVID vaccine in children under 6, starts delayed filing for older kids aliu Wed, 03/23/2022 - 09:46
Using sumo ads, Moderna makes a heavy marketing push in Japan to rebuild trust in its COVID-19 vaccine
Using sumo ads, Moderna makes a heavy marketing push in Japan to rebuild trust in its COVID-19 vaccine kdunleavy Wed, 03/23/2022 - 09:29
AbbVie goes all-in on Vuity’s unique selling point in first ad campaign for the eye drop
AbbVie goes all-in on Vuity's unique selling point in first ad campaign for the eye drop badams Wed, 03/23/2022 - 09:24
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024 fkansteiner Wed, 03/23/2022 - 09:21
Fujifilm makes yet another deal to jack up cell and gene therapy capacity
Fujifilm makes yet another deal to jack up cell and gene therapy capacity kdunleavy Tue, 03/22/2022 - 21:13
‘No small feat’: Albireo CEO talks biotech’s commercial transition amid Bylvay launch
'No small feat': Albireo CEO talks biotech's commercial transition amid Bylvay launch kdunleavy Tue, 03/22/2022 - 15:07
Merck, building on Keytruda’s landmark biomarker nod, pressures GSK’s limited I-O position with new FDA approval
Merck, building on Keytruda’s landmark biomarker nod, pressures GSK's limited I-O position with new FDA approval aliu Tue, 03/22/2022 - 10:10
As rivals eye ‘unjustified royalties,’ Pfizer partner sues to defend COVID-19 shot Comirnaty
As rivals eye 'unjustified royalties,' Pfizer partner sues to defend COVID-19 shot Comirnaty esagonowsky Tue, 03/22/2022 - 09:37
Pfizer pulls blood pressure medicines in US over cancer-causing impurities
Pfizer pulls blood pressure medicines in US over cancer-causing impurities kdunleavy Tue, 03/22/2022 - 09:36
Takeda’s Natpara relaunch bid falls flat as manufacturing concerns drag on
Takeda's Natpara relaunch bid falls flat as manufacturing concerns drag on jkeenan Tue, 03/22/2022 - 09:22
UK watchdog slaps AZ, Allergan, GSK, Sanofi and Britannia for marketing breaches
UK watchdog slaps AZ, Allergan, GSK, Sanofi and Britannia for marketing breaches nmissakian Tue, 03/22/2022 - 08:43
Argenx’s subcutaneous Vyvgart matches IV sibling in phase 3, clearing path to FDA filing this year
Argenx's subcutaneous Vyvgart matches IV sibling in phase 3, clearing path to FDA filing this year ntaylor Tue, 03/22/2022 - 06:52